In late 2012, Amigo™ received 510(k) clearance from the FDA.  The Amigo clinical study (NCT01139814) was conducted at 13 sites worldwide and enrolled over 200 patients.  Results on the trial can be found in the Publications section of our website.

Catheter Precision is currently committed to improving the use of Amigo for our physicians.  Additional trials may be planned in the near future.  Please continue to visit this page for any updates.

If you are interested in or would like to learn more about research related information regarding Amigo, please contact:





The safety and effectiveness of this device for ablation in the treatment of cardiac arrhythmias including atrial fibrillation has not been established.
© Copyright 2013-2016 Catheter Precision, Inc. All Rights Reserved.